ATAI Life Sciences N.V.·4

Jun 22, 4:15 PM ET

Gutierrez-Esteinou Rolando 4

4 · ATAI Life Sciences N.V. · Filed Jun 22, 2021

Insider Transaction Report

Form 4
Period: 2021-06-17
Gutierrez-Esteinou Rolando
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2021-06-17+752,311752,311 total
    Exercise: $15.00Exp: 2031-06-17Common Shares (752,311 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the underlying shares on June 17, 2022, and the remaining vests in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION